The Magentiq-Colo, created by Israel-based technology company Magentiq-Eye, is one of the only AI-powered colonoscopy systems in the U.S., according to a July 31 news release from the company.
Colorectal cancer is the third-leading cause of cancer related death in the U.S., and a missed polyp during a colonoscopy can lead to interval cancer, which accounts for 8 percent to 10 percent of all colorectal cancer cases in the U.S.
In 2022, a 950-patient study cited by Magentiq-Colo found the device increased adenoma detection by 26 percent, which correlates to a 35 percent decrease in patient mortality, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
